<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114145">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01695967</url>
  </required_header>
  <id_info>
    <org_study_id>version 3  03Mar2012</org_study_id>
    <nct_id>NCT01695967</nct_id>
  </id_info>
  <brief_title>Turbinate Cauterization in Pediatric Patients With Nasal Obstruction</brief_title>
  <official_title>Turbinate Cauterization in Pediatric Patients With Nasal Obstruction A Randomized Prospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eastern Virginia Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eastern Virginia Medical School</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      patients will be placed in 2 groups, with or without turbinate cautery ( a surgical method
      to reduce the size of the skin covered bones in the nose), at the time of adenoidectomy and
      tonsillectomy.  It will compare the amount of nasal congestion for each group with the idea
      that it will be less if treated with turbinate cauterization.  Assessments from baseline to
      6 months post procedure will be compared between the two groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess if inferior turbinate cautery improves nasal obstruction in children undergoing
      adenotonsillectomy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure># of participants with improved nasal obstruction score from baseline to 6 months</measure>
    <time_frame>baseline and 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Baseline assessment compared to 6 mo post surgery. The SN-5 Nasal Obstruction and Sinonasal Quality of Life instrument tools will be used to record nasal obstruction symptom scores.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>Nasal Obstruction</condition>
  <arm_group>
    <arm_group_label>Turbinate Cauterization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Turbinate Cauterization will be completed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no turbinate cauterization</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>turbinate cauterization</intervention_name>
    <arm_group_label>Turbinate Cauterization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ages 3-16

          -  obstructive sleep apnea warranting adenotonsillectomy

          -  history of daytime nasal obstruction and or mouth breathing

          -  failed medical treatment with either oral anti-histamine or nasal steroid spray.

          -  turbinate hypertrophy on Physical Exam defined by &gt;50% obstruction

        Exclusion Criteria:

          -  &lt;3 or &gt;16

          -  unwillingness to comply with study procedures

          -  congenital head and neck malformations, genetic syndromes, craniofacial anomalies

          -  no evidence of turbinate hypertrophy or symptoms of nasal obstruction

          -  pregnancy or breastfeeding

          -  bleeding disorders

          -  current therapy with coumadin or Pradaxa
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Baldassari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eastern Virginia Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chrisina Baldassari, MD</last_name>
    <phone>757-668-6200</phone>
    <email>cristina.baldassari@chkd.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Hospital of the King's Daughters</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Baldasarri, MD</last_name>
      <phone>757-388-6200</phone>
      <email>christina.baldassari@chkd.org</email>
    </contact>
    <contact_backup>
      <last_name>Laura Stone, RN</last_name>
      <phone>7573886238</phone>
      <email>stonelj@evms.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Christina Baldassari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 1, 2013</lastchanged_date>
  <firstreceived_date>September 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eastern Virginia Medical School</investigator_affiliation>
    <investigator_full_name>Cristina Baldassari M.D.</investigator_full_name>
    <investigator_title>Assistant Professor, Pediatric Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>nasal obstruction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Nasal Obstruction</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
